Skip to content

Tag: medical device

Hosted by Dr. Scott Sigman – “Dr. Atiba Jackson”

This episode is brought to you by Heron Therapeutics. Please see full Prescribing Information, including Boxed Warning or visit

If you like happy vibes with a positive patient track record, we’ve got the orthopedic surgeon for you. Meet Dr. Atiba Jackson from Dayton, OH. He is a Board-Certified Orthopedic Sports Medicine specialist, with fellowship training in sports medicine so he can provide the highest level of care for this brand of injuries. He treats complex shoulder injuries including rotator cuff, labrum, SLAP tears, instability, and dislocations. In addition to treating difficult knee injuries, including ACL tears, ligamentous injuries, meniscus tears, cartilage injuries, he also treats elbow injuries and performs elbow arthroscopy. He cares for arthritis patients, performing replacements of the shoulder, knee, and hip.

Topics include:

-His family influence in becoming an orthopedic surgeon, as his father is a family practice doctor. Dr. Jackson has strong family ties and we hear the importance of family in this episode. He also became a teenage parent, overcame the adversity and remained focused on becoming an orthopedic surgeon.

-Dr. Atiba Jackson helps train the clinical and surgical techniques at the Grandview Orthopedic Residency (DO) program. We hear about the post-grant research position they’ve developed for those in a bridge year to help them become more of a competitive applicant.

-He has social media following for promoting his private practice, Orthopedic Associates, and educating his patients. Dr. Jackson looks like Usher and uses it to his advantage when creating engaging posts.

Find out more about Dr. Atiba Jackson here.

Also, find out more about Zynrelef here:

ZYNRELEF utilizes a novel synergistic mechanism of action that combines bupivacaine with a low dose of meloxicam to overcome the challenges of the inflammatory process at the surgical site. ZYNRELEF is the first and only extended-release dual-acting local anesthetic™ (DALA™) and delivers 72 hours of postoperative pain relief via a single needle-free application. It has been clinically proven to better manage pain than standard of care bupivacaine HCl solution over 72 hours and to significantly reduce opioid utilization following surgery.

-ZYNRELEF was initially approved by the FDA in May 2021 and in December 2021, the FDA approved an expansion of ZYNRELEF’s indication.

-Limitations of Use: Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures.


See full prescribing information for complete boxed warning.

• Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use

• ZYNRELEF is contraindicated in the setting of coronary artery bypass graft (CABG) surgery

• NSAIDs cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events

ZYNRELEF is contraindicated for:

• Patients with a known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to any local anesthetic agent of the amide-type, NSAIDs, or to any of the other components of ZYNRELEF OR history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients

• Patients undergoing obstetrical paracervical block anesthesia OR coronary artery bypass graft (CABG) surgery


Cardiovascular (CV) Thrombotic Events with NSAID Use; Gastrointestinal Bleeding, Ulceration, and Perforation with NSAID Use; Dose-Related Toxicity; Risk of Use in Patients with Impaired Cardiovascular Function; Hepatotoxicity; Hypertension; Heart Failure and Edema; Renal Toxicity and Hyperkalemia; Anaphylactic Reactions; Chondrolysis; Methemoglobinemia; Exacerbation of Asthma Related to Aspirin Sensitivity; Serious Skin Reactions; Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS); Hematologic Toxicity; Masking of Inflammation and Fever.

Comments closed

Hosted by Dr. Scott Sigman – “Christy Owenby”

This image has an empty alt attribute; its file name is guest-host-orthopedic-podcast-1024x536.png

This episode is brought to you by ModMed. To learn more and see a demo of the #1 EHR system, EMA®, as well as Practice Management, Revenue Cycle Management, Analytics, Patient Engagement tools and more, visit ModMed — it’s about time.

Christy Owenby is CEO & HEALTHCARE DIGITAL STRATEGIST at Moxy Company. She founded MOXY Company to assist physicians, medical practices, medical device companies and emerging startups in healthcare with marketing, consulting, social media, public relations, brand development, creative style, and so much more. Her greatest strengths are creativity, drive, and solid determination. Christy thrives on challenges, particularly those with the goal of revolutionizing healthcare marketing.

Topics include:

-Christy’s sage advice includes you can’t start too early as a medical school student or resident and never too old to start growing your social media following.
-We discuss how the different platforms, such as Instagram, Facebook and LinkedIn, can be utilized to promote your practice, as well as providing best practices for business etiquette on social media.
-We also discuss the need to be loud and clear in your goals on social media messaging.

Find out more about Christy Owenby and Moxy Company here.

Comments closed

Hosted by Dr. Scott Sigman – “Dr. Daniel Paull”

This image has an empty alt attribute; its file name is guest-host-orthopedic-podcast-1024x536.png

This episode is brought to you by ModMed. To learn more and see a demo of the #1 EHR system, EMA®, as well as Practice Management, Revenue Cycle Management, Analytics, Patient Engagement tools and more, visit ModMed — it’s about time.

Dr. Daniel Paull is an orthopedic surgeon in solo private practice in Colorado Springs, CO. He is the Founder and CEO of Easy Orthopedics, which is disrupting the healthcare status quo by cutting out all the middlemen and delivering relationship-based care that values time. He was frustrated with the way medical care was being delivered and didn’t want an insurance company or hospital administrator telling him what to do, and getting in the middle of the relationships that he builds with patients. It’s a unique story about grit and sweat equity to start something new to help patients.

Topics include:

-We hear his story of becoming an orthopedic surgeon. Dr. Paull has degrees from NYU and University of Miami and completed residency from University of Toledo in Ohio.

-Dr. Paull is off the beaten path in a solo private practice. Dr. Paull travels to the patient’s house, hotel or office in the Colorado Springs area. He will also take office appointments, sees patient’s at other practitioner’s offices, and also has telehealth visits available. Dr. Paull is a believer in relationship-based medicine and is able to spend more time with his patients.

Find out more about Dr. Daniel Paull here

This content in this Podcast is not approved for credit by CMEfy, however, you may reflect on how this Podcast applies to your day-to-day and engage to earn AMA PRA Category 1 Credit(s)™ via point-of-care learning activities by clicking below.

Earn CMEs with CMEfy

Comments closed

Hosted by Dr. Scott Sigman – “The OG of Box Openers”

This image has an empty alt attribute; its file name is guest-host-orthopedic-podcast-1024x536.png

Medical device sales reps, listen in!

Ciro Roemer, former Company Group Chairman for Johnson & Johnson Medical Devices for North America, joins us for this episode. You’re going to want to write down these pearls of wisdom from a top orthopedic executive with 35 years of industry experience. He joined us when he was enjoying his first week of retirement. Topics include:

-It’s a team effort from medical device manufacturers to the surgeons for the best patient outcomes

-Advice from an executive in medical devices. He carried a bag and started in the trenches

-Credo where patients are #1, employees #2, community #3, stakeholders #4

-Importance of AO Foundation as the world’s leading education provider to health care professionals

Thank you to our partner OrthoLazer for making this episode of The Ortho Show possible.

Comments closed